Illuccix Prostate Cancer Psma-pet Imaging Agent Approved In Sweden
April 15, 2025
Telix Pharmaceuticals Limited announces that its prostate cancer PET imaging agent Illuccix has been granted marketing authorization by the Swedish MPA for the detection and localization